[Irinotecan plus fuorouracil/leucovorin (FOLFIRI) as a second line chemotherapy for refractory or metastatic colorectal cancer]. [electronic resource]
Producer: 20100427Description: 225-7 p. digitalISSN:- 0253-3766
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Camptothecin -- administration & dosage
- Colonic Neoplasms -- drug therapy
- Disease Progression
- Female
- Fluorouracil -- adverse effects
- Follow-Up Studies
- Humans
- Irinotecan
- Leucovorin -- adverse effects
- Male
- Middle Aged
- Neoplasm Metastasis
- Neoplasm Recurrence, Local
- Neutropenia -- chemically induced
- Prospective Studies
- Rectal Neoplasms -- drug therapy
- Remission Induction
- Survival Rate
- Vomiting -- chemically induced
- Young Adult
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.